BioSyent Inc. (TSXV:RX)
Canada · Delayed Price · Currency is CAD 15.00
0.00 (0.00%)
Aug 10, 2026, 9:30 AM EST
BioSyent Market Cap
BioSyent has a market cap or net worth of CAD 171.57 million as of August 10, 2026. Its market cap has increased by 31.20% in one year.
Market Cap
171.57M
Enterprise Value
165.92M
Revenue
45.98M
Ranking
n/a
PE Ratio
19.13
Stock Price
15.00
ChartMarket Cap Chart
Since April 24, 1997, BioSyent's market cap has increased from 13.21M to 171.57M, an increase of 1,199.25%. That is a compound annual growth rate of 9.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 171.57M | 19.67% |
| Dec 31, 2025 | 143.37M | 12.27% |
| Dec 31, 2024 | 127.69M | 17.76% |
| Dec 29, 2023 | 108.44M | 28.05% |
| Dec 30, 2022 | 84.69M | -18.50% |
| Dec 30, 2021 | 103.91M | 2.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Auxly Cannabis Group | 288.78M |
| Aurora Cannabis | 257.06M |
| Cardiol Therapeutics | 229.39M |
| TerrAscend | 225.98M |
| Organigram Global | 192.86M |
| Cannara Biotech | 189.66M |
| Medexus Pharmaceuticals | 160.20M |
| Grown Rogue International | 149.96M |